Journal · Updated 2026-08-11
The True 12-Month Cost of Every GLP-1 Path, Computed Honestly
By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify
The short answer
Twelve-month totals, assumptions stated. Insured: ~$300 ($25 copays; $600 at Medicare's $50 bridge tier). Compounded semaglutide: $1,188 committed ($99 plans), $1,548–$1,668 monthly ($129–$139). Compounded tirzepatide: $1,500–$1,668 committed ($125 upfront-billed, $139 monthly-billed), $2,028–$2,148 flexible ($169–$179). Oral Wegovy: ~$1,988 in year one at current tiers. Wegovy pens: ~$4,088 year one with the introduction, $4,188 after. Zepbound vials: $5,089 in a titration year (the cheaper early rungs), $5,388 at steady maintenance — every 45-day window made. The spread top to bottom, insured excluded: $1,188 to $5,388 — a 4.5× range for the same two molecules, which is the entire reason this site normalizes before ranking.
The failure modes, priced
Real annual costs include the mistakes the brochures don't. The 45-day lapse: one missed window at Zepbound's 10 mg reprices that fill toward $599–$1,049 — a single slip adds $150–$600 to the year, and two undo the vial program's entire advantage over resellers; the calendar is part of the price. The unlocked promo: a $169 rate that reverts to a $215 standard card mid-year adds ~$276–$552 depending on timing — which is why "is this rate locked, in writing?" is a day-one question, not a month-six discovery. The prepaid exit: leaving a $1,500 upfront annual plan in month five without a pro-rata clause forfeits ~$875 of medication never received — the refund-clause-is-the-price arithmetic. The teaser escalation: a "$133 start" that reprices to $289 at maintenance turns an advertised $1,596 year into ~$3,200 — the single most expensive misread in the market. Each failure mode has a one-sentence prevention, and all four preventions are the same sentence: get the ongoing, all-in, maintenance-dose rate — and its lock, term, and exit terms — in writing before the first payment. The annual math only works on numbers that hold still.
Questions people ask
What does a year of GLP-1 treatment actually cost?
By path: ~$300 insured; $1,188–$1,668 compounded semaglutide; $1,500–$2,148 compounded tirzepatide; ~$1,988 oral Wegovy year one; ~$4,088–$4,188 Wegovy pens; $5,089–$5,388 Zepbound vials (titration vs steady state, all 45-day windows made). Same molecules, 4.5× spread — structure is everything.
What hidden costs change the annual math?
The failure modes: a missed 45-day window (+$150–$600), an unlocked promo reverting mid-year (+$276–$552), exiting a prepaid annual plan without pro-rata refunds (up to ~$875 forfeited), or a teaser rate escalating at maintenance (+$1,600). All preventable by one habit: the ongoing rate, lock, and exit terms in writing before paying.
Is committing to a 12-month plan worth the savings?
The committed tiers save $360–$648/year over monthly-flexible rates — real money, purchased with exposure: upfront-billed plans concentrate it (read the refund clause as the price), monthly-billed commitments (bmiMD's shape) soften it. Certain-of-the-year buyers take the discount; everyone else buys the exit.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.